It is thought to arise from a combination of microvascular dysfunction, chronic inflammation, and increased interstitial pressure that may compress peripheral nerves
Therefore, we aimed to determine whether GLP-1RAs, compared with sodiumglucose cotransporter 2 (SGLT2) inhibitors, metformin or other second- or third-line glucose-lowering medications, are associated with a lower rate of new-onset adverse cardiovascular events (CVEs) among patients with NAFLD and type 2 diabetes
Understanding the precise relationship between metabolic medications and fluid dynamics is vital to managing your treatment safely and comfortably
Tirzepatide had side effects similar to other drugs that work on the same hormone system
Next Steps Ready for a doctorsupervised plan
Epigenetic dysregulation of Oxtr in Tet1-deficient mice has implications for neuropsychiatric disorders